TITLE

Repeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenation

AUTHOR(S)
Mildner, R. J.; Taub, N. A.; Vyas, J. R.; Killer, H. M.; Firmin, R. K.; Field, D. J.; Kotecha, S.
PUB. DATE
December 2001
SOURCE
Thorax;Dec2001, Vol. 56 Issue 12, p924
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background-Since few studies have assessed the repeatability of non-broncho-scopic bronchoalveolar lavage (NB-BAL), al we compared cellular counts and cytokine in concentrations in fluid obtained by standardised NB-BAL from each side of 20 intubated infants receiving extracorporeal membrane oxygenation (ECMO). Methods-Total cell counts were obtained ai from 95 paired lavages and 77 pairs were suitable for differential counts and measurement of cytokine concentrations. Results-Moderate correlation was noted between the two sides for most cell types including total cell counts and percentages of neutrophils and macrophages (R=0.70-0.84) and for cytokine concentrations (IL-8 R=0.78, IL-6 R=0.75, TNF-α R=0.64, all p⩽0.001). Using Bland-Altman analysis the mean difference between the two sides approached zero for cellular constituents (total cell counts mean difference 1.7, limits of agreement -187.5 to +190.9 x 104/m1; percentage neutrophils -3.9%, -41.5% to +33.6%; percentage macrophages 3.9%, -33.8% to +41.6%) but tended to be greater on the right for logarithmically transformed cytokine measurements (IL-8: left/right ratio 0.74, limits of agreement 0.12 to 5.45, IL-6: 0.93, 0.09 to 5.87, and TNF-α: 0.93, 0.27 to 3.16). Using linear regression with random effects to assess the variability, only the infant's age appeared to influence the cellular results but, for cytokines, only the volume retrieved affected the variability. The magnitude of the measurements, the underlying disease, the operator's experience, days on ECMO, or survival did not affect the variability. Conclusion-Measurements obtained by NB-BAL need to be interpreted with caution and strongly suggest that normalisation for the dilutional effects of saline is essential.
ACCESSION #
12915289

 

Related Articles

  • Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients. Aguslí, C.; Rañó, A.; Rovira, M.; Filella, X.; Benito, N.; Moreno, A.; Torres, A. // Thorax;Dec2004, Vol. 59 Issue 12, p1081 

    Background: A study was undertaken to evaluate the local and systemic inflammatory response associated with pulmonary complications in immunocompromised patients and potential implications regarding severity and prognosis. Methods: Levels of different inflammatory mediators were measured in the...

  • Standardized lung recruitment during high frequency and conventional ventilation: similar pathophysiologic and inflammatory responses in an animal model of respiratory distress syndrome. Krishnan, Ramesh K. M.; Meyers, Pat A.; Worwa, Cathy; Goertz, Ronald; Schauer, Galen; Mammel, Mark C. // Intensive Care Medicine;Jun2004, Vol. 30 Issue 6, p1195 

    Objective: To evaluate standardized lung recruitment strategy during both high frequency oscillation (HFO) and volume-targeted conventional ventilation (CV+V) in spontaneously breathing piglets with surfactant washout on pathophysiologic and inflammatory responses.Design:...

  • Blockade of the Fas/FasL System Improves Pneumococcal Clearance from the Lungs without Preventing Dissemination of Bacteria to the Spleen. Matute-Bello, Gustavo; Liles, W. Conrad; Frevert, Charles W.; Dhanireddy, Shireesha; Ballman, Kimberly; Wong, Venus; Green, Richard R.; Ho Yeong Song; Witcher, Derrick R.; Jakubowski, Joseph A.; Martin, Thomas R. // Journal of Infectious Diseases;2/15/2005, Vol. 191 Issue 4, p596 

    Background. The Fas/FasL system is both proapoptotic and proinflammatory. FasL is inhibited by decoy receptor-3 (DcR3), a naturally occurring decoy receptor. We determined the effects of systemic blockade of the Fas/FasL system by a DcR3 analog (DcR3-a) in mice with pneumococcal pneumonia....

  • Equine Bronchoalveolar Lavage Cytokines in the Development of Recurrent Airway Obstruction. M. Pietra; A. Peli; A. Bonato; A. Ducci; S. Cinotti // Veterinary Research Communications;Aug2007, Vol. 31 Issue 0, p313 

    Pietra, M., Peli, A., Bonato, A., Ducci, A. and Cinotti, S., 2007. Equine bronchoalveolar lavage cytokines in the development of recurrent airway obstruction. Veterinary Research Communications, 31(Suppl. 1), 313–316

  • Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage. Palmeri, S.; Tarugi, P.; Sicurelli, F.; Buccoliero, R.; Malandrini, A.; Santi, M. M.; Marcianò, G.; Battisti, C.; Dotti, M. T.; Calandra, S.; Federico, A. // Neurological Sciences;Jul2005, Vol. 26 Issue 3, p171 

    Progressive lung infiltration is a major cause of death in Niemann–Pick disease type A and B (NPA, NPB) and in the recently defined type C2. In type C1 (NPC1), the main manifestations are neurological. We report a patient with a classic, neurological, late infantile form of NPC1 disease,...

  • Drotrecogin Alfa (activated) Prevents Smoke-Induced Increases in Pulmonary Microvascular Permeability and Proinflammatory Cytokine IL-1� in Rats. Wong, S. S.; Sun, N. N.; Hyde, J. D.; Ruiz, L.; Meigs, E.; Herrin, B. R.; Fastje, C. D.; Macdonald, S. J.; Witten, M. L. // Lung;2004, Vol. 182 Issue 6, p319 

    In an established rat model of smoke inhalation injury, we conducted a dose-response study to examine the protective effects of XigrisTM [drotrecogin alfa (activated) (DrotAA)], a recombinant form of human activated protein C (APC). DrotAA is a serine protease (~55 kD molecular weight) with the...

  • Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Luca, Daniele De; Minucci, Angelo; Tripodi, Domenico; Piastra, Marco; Pietrini, Domenico; Zuppi, Cecilia; Conti, Giorgio; Carnielli, Virgilio P.; Capoluongo, Ettore // Intensive Care Medicine;Jul2011, Vol. 37 Issue 7, p1158 

    Purpose: Meconium aspiration syndrome (MAS) is a life-threatening neonatal lung injury, whose pathophysiology has been mainly studied in animal models. In such models, pancreatic secretory phospholipase A2 (sPLA2-IB) and proinflammatory cytokines present in meconium challenge the lungs,...

  • Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Chun-Hua Wang; Chien-Ying Liu; Yung-Liang Wan; Chun-Liang Chou; Kuo-Hsiung Huang; Horng-Chyuan Lin; Shu-Min Lin; Tzou-Yien Lin; Kian Fan Chung; Han-Pin Kuo // Respiratory Research;2005, Vol. 6, p42 

    Background: During the acute phase of severe acute respiratory syndrome (SARS), mononuclear cells infiltration, alveolar cell desquamation and hyaline membrane formation have been described, together with dysregulation of plasma cytokine levels. Persistent high-resolution computed tomography...

  • Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis. Dawson, Rod; Condos, Rany; Tse, Doris; Huie, Maryann L.; Ress, Stanley; Chi-Hong Tseng; Brauns, Clint; Weiden, Michael; Hoshino, Yoshihiko; Bateman, Eric; Rom, William N. // PLoS ONE;2009, Vol. 4 Issue 9, p1 

    Background: Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-γ1b (rIFN-γb) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clearance....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics